基于类器官构建泛TKI提高ET+CDK4/6抑制剂 治疗HR+ /HER2-low乳腺癌疗效的筛选工具.
Saved in:
| Title: | 基于类器官构建泛TKI提高ET+CDK4/6抑制剂 治疗HR+ /HER2-low乳腺癌疗效的筛选工具. |
|---|---|
| Alternate Title: | Development of an organoid⁃based pan-TKI precision screening platform to enhance therapeutic efficacy of ET+CDK4/6 inhibitors in HR+ /HER2 ⁃ low breast cancer. |
| Authors: | 吴迎朝1,2,3,4,5, 陈柳汕1,2,3, 梁裕琪1,3,4,5, 陈洁婷3,5, 黄俊峰5, 左谦1,3,4,5, 陈前军1,2,3,4 cqj55@163.com |
| Source: | Journal of Practical Medicine / Shiyong Yixue Zazhi. 9/25/2025, Vol. 41 Issue 18, p2786-2795. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
